- Home
- GEG vs DYAI Comparison
GEG vs DYAI Comparison
Compare GEG & DYAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GEG
- DYAI
- Stock Information
- Founded
- GEG 1994
- DYAI 1979
- Country
- GEG United States
- DYAI United States
- Employees
- GEG N/A
- DYAI N/A
- Industry
- GEG Computer Software: Prepackaged Software
- DYAI Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- GEG Technology
- DYAI Health Care
- Exchange
- GEG Nasdaq
- DYAI Nasdaq
- Market Cap
- GEG 55.6M
- DYAI 54.4M
- IPO Year
- GEG N/A
- DYAI 2004
- Fundamental
- Price
- GEG $1.89
- DYAI $1.47
- Analyst Decision
- GEG
- DYAI Strong Buy
- Analyst Count
- GEG 0
- DYAI 1
- Target Price
- GEG N/A
- DYAI $6.00
- AVG Volume (30 Days)
- GEG 23.0K
- DYAI 41.8K
- Earning Date
- GEG 02-05-2025
- DYAI 03-27-2025
- Dividend Yield
- GEG N/A
- DYAI N/A
- EPS Growth
- GEG N/A
- DYAI N/A
- EPS
- GEG 0.00
- DYAI N/A
- Revenue
- GEG $19,204,000.00
- DYAI $3,364,548.00
- Revenue This Year
- GEG N/A
- DYAI $51.30
- Revenue Next Year
- GEG N/A
- DYAI $73.26
- P/E Ratio
- GEG $17,855.18
- DYAI N/A
- Revenue Growth
- GEG 73.74
- DYAI 13.82
- 52 Week Low
- GEG $1.70
- DYAI $0.93
- 52 Week High
- GEG $2.12
- DYAI $2.67
- Technical
- Relative Strength Index (RSI)
- GEG 56.81
- DYAI 44.17
- Support Level
- GEG $1.79
- DYAI $1.35
- Resistance Level
- GEG $1.96
- DYAI $1.60
- Average True Range (ATR)
- GEG 0.05
- DYAI 0.14
- MACD
- GEG 0.00
- DYAI -0.01
- Stochastic Oscillator
- GEG 50.00
- DYAI 31.58
About GEG Great Elm Group Inc.
Great Elm Group Inc operates as an alternative asset manager focused on growing a scalable and diversified portfolio of long-duration and permanent capital vehicles across credit, real estate, specialty finance, and other alternative strategies. Along with its subsidiaries, it manages Great Elm Capital Corp, a publicly traded business development company, and Monomoy Properties REIT, LLC, an industrial-focused real estate investment trust, in addition to other investments.
About DYAI Dyadic International Inc.
Dyadic International Inc is a world-wide biotechnology platform company. The company has developed a gene expression platform for producing commercial quantities of industrial enzymes and other proteins, and has licensed this technology to third parties, such as Abengoa Bioenergy, BASF, Codexis and others, for use in industrial (non-pharmaceutical) applications. This technology is based on the Thermothelomyces heterothallica fungus, which the company named C1.